» Articles » PMID: 35146598

Alpha-Lipoic Acid Attenuates MPTP/MPP-Induced Neurotoxicity: Roles of SIRT1-Dependent PGC-1α Signaling Pathways

Overview
Journal Neurotox Res
Publisher Springer
Specialty Neurology
Date 2022 Feb 11
PMID 35146598
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulated oxidative damage plays key roles in the pathogenesis of Parkinson's disease (PD). Silent mating type information regulation 2 homolog 1 (SIRT1), a class III histone deacetylase, can directly activate peroxisome proliferator-activated receptor-c coactivator-1α (PGC-1α) and attenuate oxidative stress. Alpha-lipoic acid (ALA) is a natural antioxidant that has been demonstrated to protect PC12 cells against 1-methyl-4-phenylpyridinium (MPP). However, the underlying mechanisms related to changes in cell signaling cascades are not fully understood. In the present study, the neuroprotective effect of ALA and the potential role of ALA in the SIRT1 pathway was investigated in vitro and in a mouse model of PD. A Cell Counting Kit-8 (CCK-8) assay was performed to detect the SY5Y-SH cell viability. Immunohistochemistry, quantitative real-time polymerase chain reaction and western blot assays were used to evaluate the expression of tyrosine hydroxylase (TH), SIRT1, and PGC-1α in vivo and in vitro. Intracellular reactive oxygen species (ROS) production and tissue SOD and MDA were detected by the corresponding assay kits. The results showed that ALA notably prevented oxidative stress and neurotoxicity in vivo and in vitro against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)/MPP. Furthermore, ALA significantly increased the expression of SIRT1 and PGC-1α in vivo and in vitro in MPTP/MPP-induced models, which was reversed by the SIRT1 inhibitor EX527. These results suggested that ALA prevented oxidative stress and that neurotoxicity was involved in the upregulation of SIRT1 and PGC-1α in PD mice.

Citing Articles

Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential.

Tang M, Liu Y, Hu Z, Luo H, Zhang S, Shi C Front Aging Neurosci. 2025; 16:1454735.

PMID: 40012862 PMC: 11861300. DOI: 10.3389/fnagi.2024.1454735.


Mechanism and Clinical Application Prospects of Mitochondrial DNA Single Nucleotide Polymorphism in Neurodegenerative Diseases.

Xu M, Li T, Liu X, Islam B, Xiang Y, Zou X Neurochem Res. 2024; 50(1):61.

PMID: 39673588 DOI: 10.1007/s11064-024-04311-9.


Atractylenolide-I Ameliorates Motor Deficits and Reduces Inflammation of the Spinal Cord by SIRT1/PGC-1α Pathway in MPTP Subacute Mouse Model of Parkinson's Disease.

Gao Y, Li S, Zhang J, Zhang Y, Zhao Y, Zhang S Neuropsychiatr Dis Treat. 2024; 20:1919-1929.

PMID: 39399880 PMC: 11471068. DOI: 10.2147/NDT.S481252.


Comparative proteomic analysis of plasma exosomes reveals the functional contribution of N-acetyl-alpha-glucosaminidase to Parkinson's disease.

Zhao Y, Zhang Y, Liu X, Zhang J, Gao Y, Li S Neural Regen Res. 2024; 20(10):2998-3012.

PMID: 38993127 PMC: 11826475. DOI: 10.4103/NRR.NRR-D-23-01500.


Alpha-lipoic Acid: An Antioxidant with Anti-aging Properties for Disease Therapy.

Shanaida M, Lysiuk R, Mykhailenko O, Hudz N, Abdulsalam A, Gontova T Curr Med Chem. 2024; 32(1):23-54.

PMID: 38644711 DOI: 10.2174/0109298673300496240416114827.


References
1.
Andreassen O, Ferrante R, Dedeoglu A, Albers D, Klivenyi P, Carlson E . Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. Exp Neurol. 2001; 167(1):189-95. DOI: 10.1006/exnr.2000.7525. View

2.
Andreassen O, Ferrante R, Klivenyi P, Klein A, Dedeoglu A, Albers D . Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid. Exp Neurol. 2001; 168(2):356-63. DOI: 10.1006/exnr.2001.7627. View

3.
Andrews A, Ladenheim B, Epstein C, Cadet J, Murphy D . Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals. Mol Pharmacol. 1996; 50(6):1511-9. View

4.
Blum D, Torch S, Lambeng N, Nissou M, Benabid A, Sadoul R . Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol. 2001; 65(2):135-72. DOI: 10.1016/s0301-0082(01)00003-x. View

5.
Broussy S, Laaroussi H, Vidal M . Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat). J Enzyme Inhib Med Chem. 2020; 35(1):1124-1136. PMC: 7241506. DOI: 10.1080/14756366.2020.1758691. View